Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Neoplasms × oblimersen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Waldenstrom Macroglobulinemia 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Carcinoma, Renal Cell 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Skin Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

aldesleukin 8 Interleukin-2 8 Dacarbazine 6 fludarabine phosphate 5 Cyclophosphamide 5 fludarabine 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4 montanide ISA 51 3 Surveys and Questionnaires 3 Semaxinib 3 Radiotherapy 3 Radiation 3 Fluorouracil 3 Educational Status 3 zanolimumab 2 sonidegib 2 poly ICLC 2 binimetinib 2 Whole-Body Irradiation 2 Vinblastine 2 Vemurafenib 2 Surgical Procedures, Operative 2 Spectrum Analysis, Raman 2 Sodium Chloride 2 Photochemotherapy 2 Peptides 2 Optical Imaging 2 Mohs Surgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00518895 2011-11-07

AGENDA

Genta Incorporated

Phase 3 Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡